In a groundbreaking study involving canines with chemotherapy-resistant osteosarcoma metastases, the team administered intravenous infusions of cationic liposomes coupled with plasmid DNA encoding canine interleukin-2 (IL-2) cDNA. The gene discussed is IL2; the disease is osteosarcoma.